Dr. Haven Jesse Barlow Jr., M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 8501 Arlington Blvd, Suite 420, Fairfax, VA 22031 Phone: 703-560-8844 Fax: 703-560-7270 |
Dr. John Richard Barbour, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8316 Arlington Blvd Ste 514, Fairfax, VA 22031 Phone: 703-972-6655 Fax: 703-738-6454 |
Kapil Verma, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 10521 Rosehaven St Ste 210, Fairfax, VA 22030 Phone: 703-652-4251 Fax: 703-652-8470 |
Dr. Christopher Charles Chang, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8501 Arlington Blvd, Suite 420, Fairfax, VA 22031 Phone: 703-207-3065 Fax: 703-207-2002 |
News Archive
Biomarkers play an important role in modern cancer medicine. They are used as tools to diagnose cancers more precisely and to better predict the course of the disease.
Dendritic cells, which are responsible for teaching other immune cells to attack infected or mutated cells, face a dangerous predicament.
Genentech, a member of the Roche Group, today announced the company will present results from studies of its investigational medicine pertuzumab in HER2-positive breast cancer at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium December 6-10.
Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.
› Verified 4 days ago